logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Bladder cancer: pre-pembrolizumab NLR may predict clinical outcomes

At least 25% reduction in NLR after treatment is associated with improved outcomes.